KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Castle Biosciences (CSTL) over the last 7 years, with Q3 2025 value amounting to 0.62.

  • Castle Biosciences' Asset Utilization Ratio fell 35.75% to 0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year decrease of 35.75%. This contributed to the annual value of 0.67 for FY2024, which is 3821.04% up from last year.
  • Per Castle Biosciences' latest filing, its Asset Utilization Ratio stood at 0.62 for Q3 2025, which was down 35.75% from 0.66 recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Asset Utilization Ratio peaked at 0.67 during Q1 2025, and registered a low of 0.16 during Q1 2021.
  • In the last 5 years, Castle Biosciences' Asset Utilization Ratio had a median value of 0.39 in 2023 and averaged 0.41.
  • In the last 5 years, Castle Biosciences' Asset Utilization Ratio plummeted by 6924.28% in 2021 and then soared by 6503.51% in 2023.
  • Castle Biosciences' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then skyrocketed by 44.23% to 0.3 in 2022, then skyrocketed by 63.23% to 0.49 in 2023, then increased by 28.49% to 0.64 in 2024, then decreased by 2.31% to 0.62 in 2025.
  • Its last three reported values are 0.62 in Q3 2025, 0.66 for Q2 2025, and 0.67 during Q1 2025.